Volume 35, Issue 1 (1-2021)                   Med J Islam Repub Iran 2021 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khavanin Zadeh M, Omrani Z, Cheraghli R, Hashemaghaee M. ESR, CRP, and failure of Arterio-Venous Fistula (AVF). Med J Islam Repub Iran 2021; 35 (1) :936-939
URL: http://mjiri.iums.ac.ir/article-1-7369-en.html
Vascular & Endovascular Surgery, Golestan University of Medical Sciences, Gorgan, Iran , Dr.r.Cheraghali@goums.ac.ir
Abstract:   (1088 Views)
    Background: The survival of arteriovenous fistula (AVF) remains an important problem for hemodialysis patients, accounting for 20% of all hospitalizations related to AV access problems in western countries. We designed an observational prospective cohort study on 265 AVFs and evaluated their results after 4 months of fistula creation and its relation to laboratory tests as ESR and CRP levels.
   Methods: Wrist or antecubital AVFs  were created for patients with End-Stage renal disease. All laboratory tests (ESR and CRP) were checked quantitatively. The patients were followed-upfor at least 4 months and failure or maturation of AVFs were recorded in a checklist.
   Results: 177 (66.8%) males and 88 (33.2%) females were included. The surgeon created 161(60.8%) wrist and 98 (37%) antecubital AVFs. The mean age of patients was 53.18±17.1, ranged from 8 to 91 years old. CRP and total protein had significant differences between the two groups of failure and mature accesses (0.029 and 0.045 respectively).
   Conclusion:  High CRP level is recognized as a reliable predictor for the survival of AVF.
Full-Text [PDF 469 kb]   (344 Downloads)    
Type of Study: Original Research | Subject: Vascular & Trauma Surgery

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.